Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Cooper Cos Inc (COO) Common Stock USD0.10

Sell:$433.76 Buy:$433.99 Change: $7.01 (1.64%)
Market closed |  Prices as at close on 22 September 2021 | Switch to live prices |
Sell:$433.76
Buy:$433.99
Change: $7.01 (1.64%)
Market closed |  Prices as at close on 22 September 2021 | Switch to live prices |
Sell:$433.76
Buy:$433.99
Change: $7.01 (1.64%)
Market closed |  Prices as at close on 22 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses. CooperVision services three primary regions: the Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific. CooperVision offers spherical, aspherical, toric, multifocal and toric multifocal lens products in various modalities. CooperVision's products are primarily manufactured at its facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica and New York. CooperSurgical offers an array of products and services focused on advancing the health of families through a portfolio of products and services focusing on women's health, fertility and diagnostics.

Contact details

Address:
6101 Bollinger Canyon Rd Ste 500
SAN RAMON
94583-5177
United States
Telephone:
+1 (925) 4603600
Website:
https://www.coopercos.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
COO
ISIN:
US2166484020
Market cap:
$21.20 billion
Shares in issue:
49.30 million
Sector:
Health Care Supplies
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Albert White
    President, Chief Executive Officer, Director
  • Brian Andrews
    Chief Financial Officer, Executive Vice President, Treasurer
  • Holly Sheffield
    President - CooperSurgical
  • Daniel McBride
    Chief Operating Officer, Executive Vice President, President of CooperVision, Inc.
  • Agostino Ricupati
    Senior Vice President - Finance and Tax, Chief Accounting Officer
  • Mark Drury
    Vice President, General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.